GBM
In recurrent GBM with wild-type IDH1, high LTBP4 expression is associated with worse prognosis, highlighting the TGF-? pathway as a potential therapeutic target in GBM.
In recurrent <span class="disease" id="27270107-8-13-16">GBM</span> with wild-type IDH1, high <span class="gene" id="27270107-8-43-48">LTBP4</span> expression is associated with worse prognosis, highlighting the TGF-&beta; pathway as a potential therapeutic target in <span class="disease" id="27270107-8-164-167">GBM</span>.